Mon.May 20, 2024

article thumbnail

STAT+: PBM executives invited to testify before House panel

STAT

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT. Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

352
352
article thumbnail

Why AlphaFold 3 is stirring up so much buzz in pharma

PharmaVoice

The “Nobel Prize-worthy invention” could be worth hundreds of billions commercially — and have a deep impact on drug R&D.

306
306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality

STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing. To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens.

article thumbnail

Flipping a biotech incubator into a commercial company

PharmaVoice

How persistence led to BioLineRx’s first approved therapy and promising pipeline.

163
163
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Medical crowdfunding isn’t a solution for skyrocketing health care costs

STAT

In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

351
351
article thumbnail

Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies

PharmaVoice

Planning early, staying nimble and approaching commercialization as a team sport should be top priorities, the leaders said.

130
130

More Trending

article thumbnail

Why patient-centricity is essential to accelerate rare disease clinical research

European Pharmaceutical Review

Rare diseases affect up to 36 million people in the EU, and as many as 400 million people globally. 1,2 they are often progressive, life-limiting and incurable. Half of people diagnosed with a rare disease are children, 30 percent of whom die before they reach the age of five. 3 Significant unmet needs The path to diagnosis of a rare disease is complex, taking on average five to eight years from the onset of symptoms before a patient receives an accurate diagnosis. 4 In some countries, limited a

article thumbnail

STAT+: BIO to announce reorganization, senior leaders expected to depart

STAT

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning. A few senior leaders are expected to depart as part of the reorganization.

340
340
article thumbnail

Final report says UK infected blood scandal “should have been avoided”  

Pharmaceutical Technology

Nearly 30,000 people, including children in clinical trials, were infected with hepatitis C and HIV from contaminated blood products in the 1970s and 1980s.

130
130
article thumbnail

STAT+: A novel spinal cord stimulator treats paralysis without surgery. FDA will rule on it soon

STAT

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat. So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal.

304
304
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Unlocking biotech insights: Top 10 podcasts you need to listen to

pharmaphorum

Unlocking biotech insights: discover the latest advancements in biotech with our top picks for podcasts. Stay informed and up-to-date with industry trends and news by listening to some of the best biotech podcasts featuring expert analysis, discussions of ethical issues, and interviews with industry leaders.

124
124
article thumbnail

STAT+: Why health systems are faring better so far in 2024

STAT

Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby Boomers is keeping people in doctor’s offices, and health care providers are continuing to build capacity post-Covid. Those trends — the same ones that tanked health insurance stocks a few weeks ago — made a strong mark on nonprofit health systems’ first quarter financial reports.

Hospitals 262
article thumbnail

PDURS explained: The FDA’s new framework for adding software to drug labels

pharmaphorum

In this fireside chat webinar, experts break down the FDA's new PDURS framework for adding software to drug labels. Learn how it impacts pharma and what you need to know. Join us on Tuesday 9th July @ 07:00am PDT / 10:00am EDT / 15:00pm BST / 16:00pm CEST.

Labelling 119
article thumbnail

STAT+: Class action against UnitedHealth asks about DOJ probe transparency

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. The nonprofits rake in a strong first quarter My colleague Tara Bannow and I are absolute suckers for reading hospital financial statements. A huge amount of those documents were released last week, and the numbers mirror what  we’ve been seeing over the past several months : Not all hospitals are in dire str

Hospitals 256
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Therapies designed to dismantle cancer’s escape mechanisms show promise for patients

BioPharma Dive

Hear from IO Biotech CEO Dr. Mai-Britt Zocca about the potential of therapeutic vaccines to strip the defenses used by cancer cells to keep the immune system at bay.

Immunity 111
article thumbnail

Opinion: HHS’s proposed rule pays lip service to addressing the climate crisis, the greatest threat to human health

STAT

In April, the U.S. Department of Health and Human Services, the world’s most powerful health care agency — responsible for overseeing the largest industry in the world’s largest economy — offered a pretend proposal for regulating health care’s massive carbon footprint of 550 million metric tons of carbon dioxide-equivalent (CO2e), or greenhouse gas (GHG) emissions.

Hospitals 254
article thumbnail

Novavax investor withdraws proxy fight after Sanofi deal

pharmaphorum

Shah Capital Management has withdrawn a proxy campaign against the re-election of director at vaccines firm Novavax in the wake of its $1.2 billion alliance with Sanofi. The top-three investor in Novavax – which has been steadily raising its stake in the company in recent weeks and now holds around 7.9% – said it welcomed the Sanofi deal but warned that “does not mean our engagement is at an end” and it still believes Novavax would benefit from a stockholder on its board of directors.

Vaccines 110
article thumbnail

Opinion: Best time to deliver public health messages? When people are thinking about their health

STAT

I was 31 years old when my mother was dying of breast cancer. One day, while sitting with her in the hospital, her oncologist asked me a question no one had ever asked me before: “Have you had a mammogram yet?” Even though my mother had been diagnosed with breast cancer when she was 34, I had never thought about getting a mammogram or discussed it with my doctor.

Hospitals 240
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

ATS: Amgen, AZ say data backs Tezspire’s role in COPD

pharmaphorum

Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have a role to play in chronic obstructive pulmonary disease (COPD) – a key target indication for the drug – despite missing its primary objective in a clinical trial.

113
113
article thumbnail

STAT+: Pharmalittle: We’re reading about Sanders’ pharma pressure campaign, AstraZeneca’s new ADC factory, and more

STAT

Good morning from STAT reporter Andrew Joseph, filling in here for Mr. Pharmalot. We’ve recently been trying to experiment with just one cup of stimulation per day, but our current Case of the Mondays is really testing that commitment at the moment. As we wish you a stronger, perkier start to the week, we’ll leave you with a few tidbits.

article thumbnail

Who’s caring for those who care?

The Pharmacist

Phil Galt, a qualified pharmacist and managing director for Cegedim Rx, explores the mental health strain that pharmacists can face and asks, who’s caring for those who care? I’ve spent more than two decades working on the frontline of pharmacy. It’s always been a stressful environment and an intense workload is nothing new. But I’ve […] The post Who’s caring for those who care?

106
106
article thumbnail

The biotech news you need to read this morning

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Today, we talk about how Bernie Sanders might be hitting a wall with the drug industry, see a glimmer of potential for HIV vaccines, and introduce a new Monday fundraising feature.

Vaccines 191
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

UK clinical trial regulation may support haemophilia treatment access

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) new Notification Scheme for lower-risk clinical trials has enabled an application for a Phase IV haemophilia A clinical trial to be accepted by day 14. approximately 20 percent of UK initial clinical trial applications are anticipated to be eligible [for the MHRA’s new Notification Scheme]” The treatment, Nuwiq, is a fourth-generation recombinant FVIII is indicated for severe haemophilia A in patients undergoing major sur

98
article thumbnail

Pharmacists sentenced for illegally supplying 55 million doses of controlled drugs

The Pharmacist

Two pharmacists have received suspended prison sentences after pleading guilty to supplying Class C drugs. The offences were uncovered by an investigation by the criminal enforcement unit of the Medicines and Healthcare products Regulatory Authority (MHRA). Mandip Sidhu (47) from Littleover, Derby, was sentenced to two years imprisonment on each of five counts of supplying […] The post Pharmacists sentenced for illegally supplying 55 million doses of controlled drugs appeared first on The

99
article thumbnail

AstraZeneca announces $1.5b ADC manufacturing facility

European Pharmaceutical Review

A new $1.5 billion antibody drug conjugate (ADC) manufacturing facility in Singapore is set to increase global supply of AstraZeneca’s ADC portfolio. More about the ADC facility The planned greenfield facility will be the company’s first end-to-end ADC production site” The planned greenfield facility will be the company’s first end-to-end antibody drug conjugate production site.

article thumbnail

ATS: Vicore, Endeavor therapies show promise in IPF

pharmaphorum

Phase 2a data with drugs for idiopathic pulmonary fibrosis from Vicore and Endeavor raise hopes of disease-modifying therapy for the disease

111
111
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Vicore and Endeavor’s therapies show promise in treating IPF

Pharma Times

Both drugs have the potential to offer a disease-modifying approach to the lung disease

129
129
article thumbnail

Cervical cancer elimination in the UK is within sight with HPV vaccine

Pharmaceutical Technology

A recent study in England has shown that the HPV vaccine in teenagers reduced the rate of cervical cancer by up to 85%.

article thumbnail

KCL researchers identify key features of autoimmune diseases present in the gut

Pharma Times

Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body

105
105
article thumbnail

AstraZeneca Plans $1.5 Billion ADCs Facility in Singapore

PharmaTech

The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.

98
article thumbnail

UK pharmacists demand powers to change whooping cough prescriptions

The Guardian - Pharmaceutical Industry

Exclusive: Some pharmacies have turned away families because they have run out of the drug clarithromycin Pharmacists are calling for fresh powers to provide patients with alternative prescriptions as they warned that drugs shortages are hampering their ability to tackle whooping cough. More than 2,700 cases have been reported across England so far in 2024 – more than three times the number recorded in the whole of last year.

78